Safety and Efficacy of Paxlovid Against Omicron Variants of Coronavirus Disease 2019 in Elderly Patients.
Weng C, Xie R, Han G, Yuan Y, Li S, Wang C, Wang X, Jiang W, Jiang L.
Weng C, et al.
Infect Dis Ther. 2023 Feb;12(2):649-662. doi: 10.1007/s40121-023-00760-x. Epub 2023 Jan 25.
Infect Dis Ther. 2023.
PMID: 36696068
Free PMC article.
METHODS: Patients aged over 60 years and with mild to moderate COVID-19 were admitted to the Zhongshan Hospital MinHang MeiLong Branch, Fudan University and received either Paxlovid treatment or only conventional therapy, between April 1 and May 31, 2022. ...
METHODS: Patients aged over 60 years and with mild to moderate COVID-19 were admitted to the Zhongshan Hospital MinHang MeiLong Branc …